Co-conjugating chondroitin-6-sulfate/dermatan sulfate to chitosan scaffold alters chondrocyte gene expression and signaling profiles.
Co-conjugating chondroitin-6-sulfate (CSC) and dermatan sulfate (DS) to chitosan scaffolds improves chondrocyte differentiation and extracellular matrix (ECM) production. To further elucidate the cellular responses to CSC/DS conjugation, gene expression profiles for the rat chondrocytes cultured on the CSC/DS/chitosan and chitosan-only scaffolds were compared by reverse-transcription PCR (RT-PCR) and quantitative real-time RT-PCR (qRT-PCR). Our data unraveled that the CSC/DS/chitosan scaffold resulted in low-level expression of collagen I, IIA and X and potentiated the aggrecan, collagen II (including collagen IIB) and TIMP3 expression, but downregulated the decorin expression. Therefore CSC/DS/chitosan scaffold maintained the chondrocyte differentiation while minimized de-differentiation and hypertrophy. Furthermore, CSC/DS conjugation affected the expression of 11 genes implicated in 9 signaling pathways (as unveiled by cDNA microarray) and upregulated the expression of TGF-beta1, Sox9, BMP2, PTHrP and Ihh (as confirmed by qRT-PCR). These data suggested that the CSC/DS/chitosan scaffold potentiated the TGF-beta and Hedgehog pathways, which activated the expression of PTHrP and its downstream Sox9. The signals were transduced to elevate the expression of aggrecan, collagen II and TIMP3, and contributed to the well-differentiated chondrocyte phenotype. Altogether, this study for the first time elucidated the roles of GAGs-conjugated biomaterials in matrix production and breakdown, cellular differentiation and signal transduction at the molecular levels.
Chen
Yen-Lin
YL
Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan.
Chen
Huang-Chi
HC
Chan
Hing-Yuen
HY
Chuang
Ching-Kuang
CK
Chang
Yu-Han
YH
Hu
Yu-Chen
YC
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D048271:Chitosan / Q000378:metabolism*; D019902:Chondrocytes / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D002809:Chondroitin Sulfates / Q000378:metabolism*; D003871:Dermatan Sulfate / Q000378:metabolism*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects*; D006025:Glycosaminoglycans / Q000378:metabolism*; D008954:Models, Biological; D020411:Oligonucleotide Array Sequence Analysis; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects*
D006025:Glycosaminoglycans; D003871:Dermatan Sulfate; D002809:Chondroitin Sulfates; D048271:Chitosan